Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107540648A reveals a novel route for Dapagliflozin offering high purity and safety. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN102241663B reveals a green aqueous synthesis for Strontium Ranelate. Achieve 90-95% yield with <0.3% impurities. Ideal for cost reduction in API manufacturing.
Patent CN101475572A reveals a high-purity synthesis route for triacetylganciclovir using monoacetylguanine, offering significant cost reduction and scalability for API manufacturing.
Patent CN107987053B details a novel isomerization process for Z-type flupenthixol hydrochloride, offering enhanced purity and supply chain stability for pharmaceutical manufacturing.
Novel five-step synthesis route for 10-methoxyiminostilbene offers mild conditions and high purity. Enhances supply chain stability and reduces manufacturing costs significantly.
Patent CN104987338A reveals a low-cost method for Sitagliptin phosphate key intermediate. Achieve high purity and supply chain stability with optimized Grignard processes.
Patent CN101801984A details novel chiral phosphoramides and N-phosphonimines. Discover stable alternatives to N-sulfinylimines for cost-effective asymmetric synthesis.
Patent CN105254587A details a safer chlorination route for tianeptine sodium intermediate using industrial hydrochloric acid, ensuring high purity and supply chain stability.
Novel solid-phase secondary cyclization method for plecanatide ensures high purity and yield. Offers significant supply chain advantages for pharmaceutical intermediates manufacturing.
Advanced hybrid synthesis patent CN106589069B ensures high purity oxytocin. Reduces costs and improves supply chain reliability for pharmaceutical manufacturers globally.
Advanced patent CN119080860A details a novel refining method for 17α-hydroxyprogesterone ensuring high purity and yield for scalable pharmaceutical intermediates manufacturing supply chains.
Novel solid-phase method using ester-bond transamidation improves purity and yield for GLP-1 analogs. Cost-effective manufacturing solution for pharmaceutical intermediates.
Patent CN111732649B details continuous flow solid-phase synthesis for liraglutide, offering high purity, reduced solvent use, and scalable manufacturing for pharmaceutical intermediates.
Enzymatic synthesis patent CN100396782C offers high purity stable isotope labeled amino acids with streamlined extraction and superior 15N utilization for research.
Patent CN106478805A details a novel fragment condensation method enhancing purity and yield for GLP-1 derivatives, offering significant supply chain and cost advantages for manufacturers.
Patent CN107382697A details efficient chiral resolution for Palonosetron intermediate, ensuring high purity and supply stability for pharmaceutical manufacturing.
Patent CN112266364A reveals a metal-free hydrogenation method for tetrahydroquinoxalines using organic catalysts, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Novel Rh-catalyzed borylation method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for complex chiral building blocks.
Novel AlCl3 catalyzed route for prucalopride intermediate. High yield, safe scale-up, cost-effective manufacturing for global supply chains.
Advanced solid-phase synthesis of Liraglutide ensuring high purity and yield. Reliable supplier for pharmaceutical intermediates with scalable processes and cost efficiency.